northwest bancshares, inc. announces third quarter 2024 net income of $34 million, or $0.26 per diluted share
Net interest margin expands 13 basis points to 3.33%, inclusive of 4bps from an interest recoveryAverage deposits grew $10 million...
Month: October 2024
ati announces third quarter 2024 results
Ninth consecutive quarter with sales in excess of $1 billion Q3 2024 sales of $1.05 billion Q3 2024 net income...
masco corporation reports third quarter 2024 results
LIVONIA, Mich.--(BUSINESS WIRE)--Masco Corporation (NYSE: MAS), one of the world’s leading manufacturers of branded home improvement and building products, reported...
sanu gold announces a new target at salat east on daina project
Vancouver, British Columbia--(Newsfile Corp. - October 29, 2024) - Sanu Gold Corporation (CSE: SANU) (OTCQB: SNGCF) ("Sanu Gold" or the...
abeona therapeutics® completes pz-cel biologics license application resubmission to u.s. food and drug administration
CLEVELAND, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that the Company has resubmitted its...
dt midstream reports strong third quarter 2024 results; raises adjusted ebitda guidance
DETROIT, Oct. 29, 2024 (GLOBE NEWSWIRE) -- DT Midstream, Inc. (NYSE: DTM) today announced third quarter 2024 reported net income...
defi technologies’ valour inc. eliminates debt with recent c$5.5 million (us$4 million) payment, strengthening financial position for growth and expansion
Debt-Free Milestone: Valour Inc. has eliminated its outstanding debt with a final C$5.5 million (US$4 million) payment, completed on October...
24/7 Market News Snapshot 29 October, 2024 – GlycoMimetics, Inc. (NASDAQ:GLYC)
DENVER, Colo., 29 October, 2024 (247marketnews.com) – (NASDAQ:GLYC) are discussed in this article. GlycoMimetics, Inc. has experienced a remarkable surge...
24/7 Market News Snapshot 29 October, 2024 – GlycoMimetics, Inc. (NASDAQ:GLYC)
DENVER, Colo., 29 October, 2024 (247marketnews.com) – (NASDAQ:GLYC) are discussed in this article. GlycoMimetics, Inc. (NASDAQ: GLYC) has captured market...
janus international group reports third quarter 2024 financial results
TEMPLE, Ga.--(BUSINESS WIRE)--Janus International Group, Inc. (NYSE: JBI) (“Janus” or the “Company”), a leading provider of building product solutions and...
penske automotive group reports quarterly results
Quarterly Revenue Increases 2% to $7.6 Billion Record Quarterly Retail Automotive Service and Parts Revenue of $778.0 Million, up 14%...
corning reports strong third-quarter 2024 financial results(1) highlighting key milestones in ‘springboard’ plan to add more than $3 billion in annualized sales, and achieve operating margin of 20%, by the end of 2026
CORNING, N.Y.--(BUSINESS WIRE)--Corning Incorporated (NYSE: GLW) today announced its third-quarter 2024 results and provided its outlook for fourth-quarter 2024. Wendell...
evergold options the rockland gold property to wolfden, and wolfden prepares to drill
TORONTO, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Evergold Corp. (TSX-V: EVER, OTC: EVGUF, WKN: A2PTHZ) (“Evergold” or the “Company”) is...
scorpio tankers inc. announces financial results for the third quarter of 2024 and the declaration of a dividend
MONACO, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Scorpio Tankers Inc. (NYSE: STNG) ("Scorpio Tankers" or the "Company") today reported its...
shutterstock reports third quarter 2024 financial results
Achieves Record Revenues and Adjusted EBITDA and Increases Guidance for 2024Announces Departure of CFO and Appointment of Incoming CFO NEW...
adm endeavors provides corporate and industry update
New US$13M Facility on Track: ADM Endeavors' new 100,000 sq. ft. facility, appraised at US$13 million, is nearing completion, enhancing...
sofi technologies reports net revenue of $697 million and net income of $61 million for q3 2024, demonstrating durable growth and strong returns
SAN FRANCISCO--(BUSINESS WIRE)--SoFi Technologies, Inc. (NASDAQ: SOFI), a member-centric, one-stop shop for digital financial services that helps members borrow, save,...
skye bioscience names independent director paul grayson as chairman of the board
SAN DIEGO, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on...
sagimet biosciences announces successful completion of end-of-phase 2 interactions with fda on the development of denifanstat for mash; phase 3 program initiation expected by end of 2024
The planned registration program consists of two double-blind, placebo-controlled multicenter Phase 3 trials, FASCINATE-3 and FASCINIT, to evaluate the safety...
atha energy announces appointment of new board member and chief financial officer
VANCOUVER, British Columbia, Oct. 29, 2024 (GLOBE NEWSWIRE) -- ATHA Energy Corp. (TSXV: SASK) (FRA: X5U) (OTCQB: SASKF) (“ATHA”) holder...
crocs, inc. reports better-than-expected third quarter results and adjusts full year 2024 outlook
Third Quarter Diluted EPS Up 17% to $3.36 and Adjusted Diluted EPS Up 11% to $3.60 Third Quarter Revenues Increase...
invivyd reports preliminary third quarter 2024 results, withdraws prior financial guidance, and targets near-term profitability
Preliminary Q3 2024 PEMGARDA™ (pemivibart) net product revenue of $9.3 million; Invivyd ended Q3 2024 with approximately $107 million in...
invivyd phase 3 long-term exploratory clinical efficacy data shows pemgarda™ (pemivibart) provided substantial protection from symptomatic covid-19 versus placebo over six months of follow-up, with no additional doses, in immunocompetent participants
Following strong protection (84% relative risk reduction versus placebo) demonstrated through month 6 with pemivibart, CANOPY clinical trial participants were...
rithm capital corp. announces third quarter 2024 results
NEW YORK--(BUSINESS WIRE)--Rithm Capital Corp. (NYSE: RITM; “Rithm Capital,” “Rithm” or the “Company”) today reported the following information for the...
b. riley financial secures $236 million in cash proceeds from brands assets
LOS ANGELES, Oct. 29, 2024 /PRNewswire/ -- B. Riley Financial, Inc. (NASDAQ: RILY) ("B. Riley" or the "Company"), a diversified...
immunic to participate in industry, scientific and investor conferences in november
NEW YORK, Oct. 29, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small...
strong portfolio and strategic priorities support phillips 66 third-quarter results
HOUSTON--(BUSINESS WIRE)--Phillips 66 (NYSE: PSX), a leading integrated downstream energy provider, announced third-quarter earnings. “Our employees continue to execute our...
captivision announces venture at dream hollywood hotel
MIAMI and SEOUL, Korea, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Captivision Inc. (“Captivision” or the “Company”) (Nasdaq: CAPT), a pioneer...
bioxcel therapeutics to present at thinkequity conference
NEW HAVEN, Conn., Oct. 29, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence...
hayward holdings announces third quarter fiscal year 2024 financial results
CHARLOTTE, N.C.--(BUSINESS WIRE)--Hayward Holdings, Inc. (NYSE: HAYW) (“Hayward” or the “Company”), a global designer, manufacturer and marketer of a broad...
pfizer reports strong third-quarter 2024 results and raises 2024 guidance
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) reported financial results for the third quarter of 2024 and raised its full-year 2024...
bitfarms nominates andrew j. chang for election to the board of directors
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated March 8, 2024,...
veritone to manage and monetize court tv’s expansive digital library
DENVER--(BUSINESS WIRE)--Veritone, Inc. (NASDAQ: VERI), a leader in building human-centered enterprise AI solutions, today announced it will manage and monetize...
glycomimetics enters into acquisition agreement with crescent biopharma
ROCKVILLE, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (NASDAQ: GLYC) announced today it has entered into an acquisition agreement with Crescent Biopharma, Inc. (“Crescent”),...
axsome therapeutics presents data from multiple programs spanning its innovative neuroscience portfolio at psych congress 2024
NEW YORK, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel...
american tower corporation reports third quarter 2024 financial results
BOSTON--(BUSINESS WIRE)--American Tower Corporation (NYSE: AMT) today reported financial results for the quarter ended September 30, 2024. Steven Vondran, American...
msci reports financial results for third quarter and nine months 2024
NEW YORK--(BUSINESS WIRE)--MSCI Inc. (“MSCI” or the “Company”) (NYSE: MSCI), a leading provider of critical decision support tools and services...
new marqeta research finds tremendous opportunity for credit providers to rethink customer loyalty
LAS VEGAS--(BUSINESS WIRE)--Traditional approaches to credit card loyalty have shifted as more people use digital payments, and financial services companies...
kiora pharmaceuticals receives investigational new drug approval to initiate abacus-2, a phase 2 clinical trial of kio-301 for the treatment of retinitis pigmentosa
Encinitas, California--(Newsfile Corp. - October 29, 2024) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced it...
coya therapeutics announces positive results of a double-blind study of subcutaneous low-dose interleukin-2 (ld il-2) in alzheimer’s disease (ad) presented at the clinical trials on alzheimer’s disease conference (ctad24) in madrid (spain)
HOUSTON--(BUSINESS WIRE)--Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance regulatory...